Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature

Author： Merl MY   Hoimes CJ   Pham T   Saif M Wasif  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.9, 2009-09, pp. : 1257-1264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies

By Ghiringhelli François  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 758-764

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

By Shitara Kohei  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 787-793

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

By Madajewicz Stefan  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 772-778

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine plus capecitabine has modest activity in the treatment of metastatic renal cancer refractory to or unsuitable for immunotherapy

By  

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Combined treatment with gemcitabine plus oxaliplatin shows encouraging efficacy in patients with relapsed or cisplatin-refractory germ cell tumours

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite